BFIC
BIIB icon

Bedell Frazier Investment Counselling’s Biogen BIIB Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,318
Closed -$6.07M – 109
2024
Q3 		$6.07M Buy
31,318
+17,628
+129% +$3.69M 1.45% 23
2024
Q2 		$3.17M Buy
13,690
+593
+5% +$129K 0.77% 41
2024
Q1 		$2.82M Buy
+13,097
New +$3.07M 0.71% 42
2018
Q4 		– Sell
-25,510
Closed -$9.01M – 48
2018
Q3 		$9.01M Buy
25,510
+128
+0.5% +$44.1K 2.49% 13
2018
Q2 		$7.37M Sell
25,382
-475
-2% -$134K 2.16% 25
2018
Q1 		$7.08M Sell
25,857
-60
-0.2% -$18.6K 2.5% 22
2017
Q4 		$8.26M Buy
25,917
+363
+1% +$116K 3.07% 16
2017
Q3 		$8M Sell
25,554
-27,960
-52% -$8.28M 3.69% 10
2017
Q2 		$14.5M Buy
53,514
+27,307
+104% +$7.22M 5.3% 3
2017
Q1 		$7.17M Buy
26,207
+1,762
+7% +$498K 2.72% 14
2016
Q4 		$6.93M Buy
24,445
+975
+4% +$289K 2.73% 13
2016
Q3 		$7.35M Buy
23,470
+1,779
+8% +$527K 3.04% 11
2016
Q2 		$5.2M Buy
21,691
+7,546
+53% +$1.99M 2.57% 19
2016
Q1 		$3.68M Buy
14,145
+1,166
+9% +$308K 1.9% 25
2015
Q4 		$3.98M Buy
+12,979
New +$3.73M 1.97% 23
2015
Q3 		– Sell
-15,199
Closed -$6.14M – 53
2015
Q2 		$6.14M Buy
15,199
+5,636
+59% +$2.26M 2.44% 14
2015
Q1 		$4.04M Sell
9,563
-6,952
-42% -$2.74M 1.68% 27
2014
Q4 		$5.61M Buy
+16,515
New +$5.34M 2.75% 10

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bedell Frazier Investment Counselling's BIIB Position: Q4 2024 in Review

Bedell Frazier Investment Counselling sold out of Biogen (BIIB) in Q4 2024, closing a stake of 31,318 shares — an estimated $6.07M sold.

Bedell Frazier Investment Counselling first reported a position in BIIB in Q4 2014 and held it in 18 quarters. The position peaked at $14.5M in Q2 2017. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Bedell Frazier Investment Counselling reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Bedell Frazier Investment Counselling sold 31,318 Biogen shares in Q4 2024, an estimated $6.07M.
  • Bedell Frazier Investment Counselling first reported a position in Biogen in Q4 2014 and held it in 18 quarters.
  • Bedell Frazier Investment Counselling's Biogen position peaked at $14.5M in Q2 2017.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Bedell Frazier Investment Counselling's 13F filing for Q4 2024, filed 12 Feb 2025.